![Page 1: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/1.jpg)
Άγγελος Παπανικολάου MD,
Ειδικευόμενος Καρδιολογίας,
A’ Πανεπιστημιακή Καρδιολογική Κλινική, ΓΝΑ ‘Ιπποκράτειο’
![Page 2: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/2.jpg)
Endovascular access & closure
2
Seldinger SI. Catheter replacement of the needle in
percutaneous arteriography; a new technique. In Acta
Radiol. 1953 May;39(5):368-76.
Half a centuryof manual compression
![Page 3: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/3.jpg)
3
Seldinger Technique
Needle with cannula
inserted
Needle withdrawn
until there is blood flow
Inner cannula removed
& guidewire inserted
Needle removed
Catheter over guidewire Guidewire removed
leaving catheter in
artery
![Page 4: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/4.jpg)
![Page 5: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/5.jpg)
![Page 6: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/6.jpg)
6
![Page 7: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/7.jpg)
The Anatomy
![Page 8: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/8.jpg)
Allen’s Test - Can be performed ± Oximetry
test
Peripheral vascular diseases. Edgar van Nuys Allen, MD and others with associates in the Mayo
Clinic and Mayo Foundation; 2nd edition, Philadelphia, Saunders, 1955.
![Page 9: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/9.jpg)
Allen’s Test - Can be performed ± Oximetry
test
We recommend that, in the presence of an abnormal AT, the RA should not be used for cardiac catheterization unless the risk of using the femoral approach is excessive. Greenwood et al. JACC Vol. 46, No. 11, 2005, 2005:2013–7
![Page 10: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/10.jpg)
Radial Access: proximal to styloid process – Not really the wrist!
![Page 11: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/11.jpg)
![Page 12: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/12.jpg)
![Page 13: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/13.jpg)
Complications of femoral approach
![Page 14: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/14.jpg)
![Page 15: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/15.jpg)
HEMATOMA RETROPERITONIAL
![Page 16: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/16.jpg)
AV FISTULA
![Page 17: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/17.jpg)
PSEUDOANEURYSM
![Page 18: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/18.jpg)
ARTERIAL THROMBOSIS
![Page 19: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/19.jpg)
HEMATOMA
![Page 20: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/20.jpg)
Radial Artery Complications
• 1372 Procedures
Asymptomatic radial occlusion 4.7%
Symptomatic radial occlusion 0.2%
Significant hematoma 0.2%
Significant pseudoaneurysm 0.2%
• Worst Complication
Perforation →Compartment Syndrome 1 Case
GR. Barbeau, et.al. ACC 2006)
![Page 21: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/21.jpg)
SPASM
![Page 22: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/22.jpg)
HEMATOMA
![Page 23: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/23.jpg)
FEMORAL HEMOSTASIS-MANUAL
COMPRESSION
![Page 24: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/24.jpg)
FEMORAL HEMOSTASIS-FEMOSTOP
![Page 25: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/25.jpg)
Arterial femoral closure devices
25
![Page 26: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/26.jpg)
Femoral Haemostasis
Potential advantages of closure devices:
bed rest
increased comfort
reduced cost
pain and associated ‘vagal’ reactions
complications
![Page 27: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/27.jpg)
Types of VCD
27
![Page 28: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/28.jpg)
Closure devices
Clips / Sutures
Angioseal DuettVasosealStarClose
Angiolink
Onux
Perclose
X-site
SuturaQuickseal (gel foam)
BioIntervention
Syvek
FloSeal
Biodisc
ExoSeal
Collagen & Thrombin
![Page 29: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/29.jpg)
Duett
Collagen and thrombin
Intra arterial balloon during thrombin delivery
Seals artery and tissue tract
Balloon then removed
Delivery followed by short period of manual compression
5F to 9F
![Page 30: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/30.jpg)
3F Duett
catheter
existing
sheath
![Page 31: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/31.jpg)
Vasoseal
Extravascular collagen plug (un-anchored)
Delivery followed by short period of manual compression
VasosealVHD
Vasoseal ES – 5F to 8F
![Page 32: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/32.jpg)
![Page 33: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/33.jpg)
AngioSeal
6F and 8F devices
Components
Biodegradable anchor (intra-arterial)
collagen plug (extra-arterial)
3-0 Vycril suture (with clinch knot)
![Page 34: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/34.jpg)
![Page 35: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/35.jpg)
Angioseal evidence
Kussmaul WG 3rd, et al Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol. 1995; 25:1685–1692.
Ward SR et al Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol. 1998; 81:569 –572.
Chevalier B, et al Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv. 2003; 58:285–291.
Chung J, Lee DW, Kwon OS, Kim BS, Shin YS. Angio-Seal™ Evolution™ versus Manual Compression for Common Femoral Artery Puncture in Neurovascular DiagnosticAngiography : A Prospective, Non-Randomized Study. J Korean Neurosurg Soc. 2011 Mar;49(3):153-6.
![Page 36: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/36.jpg)
Evolution Registry
All CATH PCI P
Device successfully deployed
Hemostasis by device
(N = 1004)
99.7%
97.8%
(N = 575)
99.8%
99.0%
(N=429)
99.5%
96.3%
Value
0.581
0.005
Time to hemostasis (cumulative)
<1 min
1-5 min
Additional hemostasis methods required
85.4%
98.3%
2.8%
88.0%
98.9%
1.4%
81.9%
97.4%
4.6%
0.006
0.061
0.002
Minor adverse events
Bleeding requiring 30+ minutes of manual 1.4% 0.0% 3.3% <0.001
compression
Ipsilateral hematoma >10 cm
Any minor adverse events
1.0%
2.4%
0.5%
0.5%
1.6%
4.9%
0.108
<0.001
Evolution AngioSeal RegistryTCT 2009
Death
Any major adverse events
--
4 (0.4%)
--
1 (0.2%)
--
3 (0.7%)
--
0.319
![Page 37: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/37.jpg)
StarClose
5-6F femoral artery access site
nitinol clip
4mm diameter, 0.008” thick
![Page 38: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/38.jpg)
![Page 39: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/39.jpg)
Clip Study
Diagnostic Arm - ITT
Mean Time to Hemostasis (min)
Median Time to Hemostasis (min)
Mean Time to Ambulation (min)
Major Complications (% pt based)
Minor Complications (% pt based)
Mean Time to Dischargeability (hours)
Compression
72 pts
15.5
15.0
269
0
1.4%
5.2
P value
<0.001
<0.001
<0.001
--
1.000
<0.001
StarClose
136 pts
1.5
.3
163
0
2.2%
3.5
CLIP
Clip CLosure In Percutaneous Procedures
Hermiller et al., JIC 2005;17: 504-510
![Page 40: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/40.jpg)
ExoSeal
6F extra-vascular closure device
painless deployment mechanism
delivers a poly-glycolic acid (PGA) plug atop the femoral artery
ECLIPSE trial led to CE mark (0% complications)
![Page 41: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/41.jpg)
Perclose
TechStar
7F - 1 suture
ProStar XL
8F and 10F – 2 sutures
Closer
6F – 1 suture
Knot making tool
3-0 braided polyester (non-absorbable)
![Page 42: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/42.jpg)
![Page 43: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/43.jpg)
Techstar/Prostar evidence
Gerckens U, Grube E. Management of arterial puncture site after catheterization
procedures: evaluating a suture mediated closure device. Am J Cardiol. 1999 ;83:1658
–1663.
Baim DS, Suture-mediated closure of the femoral access site after cardiac
catheterization: results of the Suture To Ambulate aNd Discharge (STAND I and
STAND II) trials. Am J Cardiol. 2000; 85:864–869.
Carere RG. Suture closure of femoral arterial puncture sites after coronary
angioplasty followed by same-day discharge. Am Heart J. 2000; 139(pt 1):52–58.
Noguchi T. A randomised controlled trial of Prostar Plus for haemostasis in patients
after coronary angioplasty. Eur J Vasc Endovasc Surg. 2000;19:451– 455.
Rickli H Comparison of costs and safety of a suture mediated closure device with
conventional manual compression after coronary artery interventions. Catheter
Cardiovasc Interv. 2002; 57: 297–302.
![Page 44: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/44.jpg)
Generation 1
25Fsurgical cutdown
Generation 2
21Fsurgical cutdown
Generation 3
18FPercutaneous
CoreValve TAVI & Prostar 10 XL
![Page 45: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/45.jpg)
needles
![Page 46: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/46.jpg)
![Page 47: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/47.jpg)
Usually perfect results in 18 F holes
![Page 48: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/48.jpg)
![Page 49: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/49.jpg)
![Page 50: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/50.jpg)
Arterial Closure Devices:
Additive Complications
Infection
Device embolization
Vascular obstruction – ischemia
![Page 51: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/51.jpg)
VCDs vs manual compression
![Page 52: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/52.jpg)
52
![Page 53: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/53.jpg)
Nikolsky et al, JACC, 2004;44:1200-9Vaitkus, JIC, 2004;16:243-6
OR (95% Cl)
1.00.1Favors device
JACC meta-analysis
JIC meta-analysis
0.1 1.0 10.0
1.13[0.89,1.38]
1.00[0.96,1.03]
Heterogeneity test
P-value
0.22
Not available
10.0Favors manual compression
Nikolsky et al, JACC, 2004;44:1200-9
Vaitkus, JIC, 2004;16:243-6
Any Closure Device Versus Manual
Compression in PCI Studies
![Page 54: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/54.jpg)
OR (95% Cl)
1.00.1Favors device
JACC meta-analysis
JIC meta-analysis
0.1 1.0 10.0
0.83[0.61,1.14]
0.51[0.45,0.58]
Heterogeneity test
P-value
NS
NS
AngioSeal Versus Manual Compression
in PCI Studies
10.0Favors manual compression
Nikolsky et al, JACC, 2004;44:1200-9
Vaitkus, JIC, 2004;16:243-6
![Page 55: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/55.jpg)
4.94%
0.52%
1.11%
MC VCD MC VCD
Diagnostic PCI
P = 0.01
P < 0.001
2.35%
12,937 consecutive patients through a prospective registry from 2002 to 2005
Manual compression 2,941 (23%) and VCD 9,996 (77%)
Angioseal 82% Perclose 17% Other 1%
VCDs vs MC in registry data
Arora et al. AHJ 2007; 53(4): 606-611
50% reduction with VCDs
![Page 56: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/56.jpg)
VCDs vs MC by propensity matching
56 Allen DS, Am J Cardiol. 2011 Jun 1;107(11):1619-23
Closure Device
(n = 1,162)
Manual Compression
(n = 1,162)
P Value
Major Bleeding
Entry Site
Other/Unknown
2.4%
0.6%
0.8%
5.2%
1.7%
1.8%
< 0.001
0.012
0.03
Stroke 0 0.5% 0.03
Pseudoaneurysm 0.3% 1.1% 0.03
In-Hospital Mortality 0.3% 0.9% 0.07
manual
compression;
6,5%
suture-based;
1,4%
collagen
plug-based;
3,4%
0,0%
2,0%
4,0%
6,0%
8,0%
![Page 57: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/57.jpg)
P<0.001P<0.001
Rickli et al., Cath Card Interv 2002;57:297-302
P<0.001
reduction 13%
Cost:
Perclose vs Manual Compression
![Page 58: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/58.jpg)
Resnic et al,
Am J Cardiol 2007, 99:766-770
Cost:
AngioSeal vs Manual Compression
Routine use of AngioSeal for PCI results in net cost savings of $44 in
the following conditions:
Cost of VCD< $235 and of MC > $67
Rates of access site bleeding < 2.5% with VCD and > 2.2% with MC
Rates of pseudoaneurysm < 1.67% with VCD and >1.01% with MC
Cost of access site bleeding > $2,104
![Page 59: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/59.jpg)
Circulation 2 Nov 2010
Patients should undergo a femoral angiogram
(Class IC)
Vascular complications rates below 1% in 5F diagnostic angiography
(Class IC)
VCDs “reasonable” after PCI to achieve
faster hemostasis and shorter duration of bed rest,
and possibly increase patient comfort
(Class IIaB)
VCDs not routinely to reduce vascular complications
(Class IIIB)
![Page 60: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/60.jpg)
Radial haemostasis
60
![Page 61: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/61.jpg)
Hemostasis after TRA is successful
Zero bleeding
P. Agostoni’s meta-analysis
J Am Coll Cardiol. 2004 Jul 21;44(2):349-56.
S. Jolly RIVAL
Lancet. 2011 Apr 23;377(9775):1409-20.
Romangoli E. RIFLES-STEACS
TCT 2011
![Page 62: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/62.jpg)
Manual compression
& rolled gauze
inexpensive,
widely available
too tight
not very secure,
personnel required
![Page 63: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/63.jpg)
HemoBand
inexpensive,
widely available
venous pressure
hand discomfort
![Page 64: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/64.jpg)
RadiStop
uncomfartable,
pt cannot use hand,
needs two hands to apply
![Page 65: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/65.jpg)
Accumed band
easy to apply venous pressure,
no point compression
![Page 66: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/66.jpg)
TR band
easy to apply,
visualizes puncture,
reduces occlusion by half,
patent hemostasis
moderately priced
![Page 67: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/67.jpg)
Helix
inexpensive,
easy to apply,
visualizes puncture,
focused pressure,
patent hemostasis
![Page 68: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/68.jpg)
Radial occlusion
68
![Page 69: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/69.jpg)
Today’s TRA practice
Symptomatic radial occlusion
requiring medical attention
0.2% in radial group
NSTE-ACS and STEMI(n=7021)
Radial Access(n=3507)
![Page 70: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/70.jpg)
98% of patients have a (+) Allen test
(+) Allen test patients do well
without the radial artery
![Page 71: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/71.jpg)
Smaller sheaths lead to
less spasm & less occlusion
Dahm JB et al Cathet Cardiovasc Intervent 2002
![Page 72: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/72.jpg)
Spaulding C et al. Cathet Cardiovasc Diagn 1996;39:365-70
100
80
No Heparin(n=49)
UFH2000-3000(n=119)
UFH5000(n=210)
71%
60
P<0.05
40
24%
20
4.3%
0
Heparin anti-coagulation prevents RAO
415
consecutive patients
![Page 73: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/73.jpg)
Patent hemostasis prevents RAO
The PROPHET Study
Pancholy S et al. Cath and Card Interv 2008; 72:335–340
436 patients
75% decrease
![Page 74: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/74.jpg)
Early and safe discharge
![Page 75: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/75.jpg)
Bernat I et al, Am J Cardiol. 2011 Jun 1
Ulnar artery compression
to recanalize RAO
![Page 76: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/76.jpg)
CABG patients do well
without the radial artery
76
No occurrence of hand ischemia in
over 3000 reported patients
undergoing radial artery grafts.
Taggart D., editorial in Heart 1999; 82:409-10
To achieve similar complications
(~2% RAO) in TRA we need to cath
150.000 patients
![Page 77: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/77.jpg)
Conclusions for TRA
77
Compression with a device
Perform patent hemostasis
Anti-coagulation
Vasodilators intra-arterial
Smaller, shorter, hydrophilic sheaths
Ulnar compression if RAO.
![Page 78: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/78.jpg)
The secret to a perfect closure…
….is a perfect and 1st puncture
Puncture
above CFA bifurcation and
below Inferior Epigastric Artery
![Page 79: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/79.jpg)
NSTE-ACS and STEMI
(n=7021)
Radial Access
(n=3507)
Femoral Access
(n=3514)
Primary Outcome: Death, MI, stroke
or non-CABG-related Major Bleeding at 30 days
Randomization
RIVAL Study Design
Key Inclusion:
• Intact dual circulation of hand required
• Interventionalist experienced with both (minimum 50 radial
procedures in last year)
Jolly SS et al. Lancet 2011.
Blinded Adjudication of Outcomes
![Page 80: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/80.jpg)
Other Outcomes
Radial(n=3507)
%
Femoral(n=3514)
%HR 95% CI P
Major Vascular Access Site Complications
1.4 3.7 0.37 0.27-0.52 <0.0001
Major Bleeding
TIMI Non-CABG Major Bleeding
0.5 0.5 1.00 0.53-1.89 1.00
ACUITY Non-CABG Major Bleeding
1.9 4.5 0.43 0.32-0.57 <0.0001
Jolly et al, Lancet 2011
![Page 81: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/81.jpg)
RIVAL study
7021 patients with ACS
undergoing PCI
No difference in MACE
– death, MI, stroke
Trend for less major
bleeding with radial
access, depending on the
bleeding definition
Less vascular
complications with radial
access
Special benefit for radial
in STEMI pts
Jolly et al, Lancet 2011
Primary endpoint - NACE
Non CABG major bleeding
![Page 82: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/82.jpg)
![Page 83: PCI σε πολυαγγειακή νόσο - Livemedia.gr · 0.1 1.0 Favorsdevice JACC meta-analysis JIC meta-analysis 0.1 1.0 10.0 1.13[0.89,1.38] 1.00[0.96,1.03] Heterogeneity test](https://reader035.vdocuments.pub/reader035/viewer/2022081523/5fe2317e63d82f6275457aaa/html5/thumbnails/83.jpg)